| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 25, 2017
DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today reinforced consistent results for its IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with two new sub-analyses from the...
-
Apr 25, 2017Three-Year VeClose Trial and One-Year WAVES Study Data Presented at Charing Cross
DUBLIN and LONDON - April 25, 2017 - Medtronic plc (NYSE: MDT) today announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data from the WAVES study. Both results...
-
Apr 24, 2017New Platform to Offer Flexibility, Ease of Use, Improved Registration and Advanced Visualization for Custom Procedural Workflows
DUBLIN and LOS ANGELES - April 24, 2017 - Medtronic plc (NYSE:MDT) today launched its new StealthStation(TM) technology at the American Academy of Neurological Surgeons (AANS) annual conference in...
-
Apr 20, 2017
DUBLIN - April 20, 2017 - Medtronic plc (NYSE: MDT) announced its sponsorship of the 23rdParkinson's Unity Walk which will be held on April 22, 2017, in New York City. Beginning at 8:30 a.m. EDT,...
-
Apr 20, 2017New Data from the Global ENGAGE Registry, IN.PACT Admiral Global Study, and VeClose Study Among Key Presentations
LONDON and DUBLIN - April 20, 2017 - Medtronic plc (NYSE: MDT) today announced key clinical studies for its leading vascular interventional portfolio will be featured at the annual 2017 Charing...